Tenet Reports Results for the Second Quarter Ended June 30, 2020 and Provides Update on Effects of COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tenet Healthcare (THC) Tops Q2 EPS by $1.97
August 3, 2020 4:19 PM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $1.26, $1.97 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $3.65 billion versus the consensus estimate of $3.76 billion.
Net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20 versus net income from continuing operations of $24 million, or $0.23 per diluted share, in 2Q19Consolidated Adjusted EBITDA of $732 million in 2Q20 versus $669 million in 2Q19Federal stimulus support received was critical in addressing pandemic challenges, allowing uninterrupted response across our care facilitiesExperienced pronounced volatility in... More